NCT06054906View on ClinicalTrials.gov

Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Gastric Cancer
Interventions
DRUG

sintilimab+metronomic PLOF

"Drug: Sintilimab 200mg iv d1 Q3W, 2cycles~Drug: Paclitaxel 60 mg/m2, d1, QW,6cycles~Drug: Oxaliplatin 50 mg/m2, d1, QW, 6cycles~Drug: 5-fluorouracil 425mg/m2 ,d1 ,QW, 6cycles"

Trial Locations (1)

Unknown

RECRUITING

Huashan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Huashan Hospital

OTHER